Clinical Trial Update: Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary

View source ↗

Summary

AstraZeneca-sponsored trial in Hungary evaluating atypical antipsychotics for affective symptoms in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Atypical antipsychotics (class)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Affective Symptoms | Status: COMPLETED